Aripiprazole (Abilify Maintena®)

Assessment Status Rapid Review Complete
HTA ID -
Drug Aripiprazole
Brand Abilify Maintena®
Indication For maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole
Assessment Process
Rapid review commissioned 02/07/2014
Rapid review completed 06/08/2014
Rapid review outcome Full Pharmacoeconomic Evaluation not Recommended